Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Ind. FD Launches Program to Divert Non-Emergency 911 Calls to Nurses
The Terre Haute Fire Department (THFD) has launched the Crosswalk to Care program to divert low‑acuity 911 calls to registered nurses for appropriate care navigation. Over the past seven years, THFD’s run calls grew by 450 annually, with roughly 20%—about 2,800 of 15,000 yearly runs—being non‑emergencies. Dispatchers now use a quick triage script to transfer these calls to a Dallas‑based nurse hub, where callers receive guidance toward urgent‑care, dental, mental‑health or prescription services. The initiative, already piloted in Indianapolis, incurs no upfront municipal cost, as Crosswalk is reimbursed by insurers.
Chinese Trial Backs Base-Editing Drug for Thalassaemia
A Chinese investigator‑led trial of CorrectSequence Therapeutics' ex vivo base‑editing drug CS‑101 showed that all five patients with transfusion‑dependent beta‑thalassaemia became transfusion‑independent after a single infusion, with an average cessation time of 16 days and sustained hemoglobin gains over three months....
Meth Patients Face Dental Crisis Amid Medicaid Gaps
You check the heart, the lungs, the skin, the reflexes. Then you skip the mouth entirely. A dentist at a safety-net clinic in Massachusetts treated a patient who had been on methamphetamine for seven years. Every tooth decayed. Gums bleeding...
Sobi Reports Health Canada Approval of Empaveli for C3G and Primary IC-MPGN
Health Canada has granted approval for Empaveli (pegcetacoplan) to treat patients aged 12 and older with C3 glomerulopathy (C3G) or primary immune‑complex membranoproliferative glomerulonephritis (IC‑MPGN). The decision follows the Phase III VALIANT trial, which demonstrated a 68% reduction in proteinuria, stabilization...
WHO Unveils Global Curriculum Guide for Community Health Workers
The World Health Organization today launched a Global Curriculum Guide for Community Health Workers and a step‑by‑step integration manual. The resources are intended to standardize training, strengthen primary health care systems and help ministries of health scale community health worker...
X‑rays Mislead Knee Osteoarthritis Treatment Decisions
Osteoarthritis Of The Knee... Thread #1... of 4 "Bone on bone." "Your cartilage is worn away." "You have the knee of a 90 year old." I've heard these phrases bantered about thousands of times in 25 years. They are very common...
America’s Healthcare Innovation Problem
The article argues that U.S. healthcare innovation suffers from a culture that declares success too early and hides failure, using examples from Medicare Advantage and the Theranos scandal. It highlights how funding, valuations, and hype often replace rigorous outcome evaluation,...
Meal Delivery and Phone Counseling Cut Veteran Blood Pressure in New Trial
A randomized trial led by University of Michigan and VA Ann Arbor found that two weeks of home‑delivered DASH‑SRD meals followed by five phone‑based dietitian sessions reduced blood pressure in middle‑aged and older veterans with hypertension and obesity. The study,...
CDC Reports Teen Birth Rate Falls to Historic Low of 11.7 per 1,000 in 2025
The Centers for Disease Control and Prevention released provisional data showing a 7% decline in U.S. teen births in 2025, bringing the rate to 11.7 births per 1,000 females aged 15‑19 – the lowest level on record. The drop, representing...
CNN Debuts Kara Swisher’s Six‑Part Docuseries on Extending Human Lifespan
CNN launched a six‑part documentary series titled “Kara Swisher Wants to Live Forever,” premiering Saturday, April 11, 2026. Hosted by veteran tech journalist Kara Swisher, the series probes the science, technology and commercial forces shaping human longevity. The debut places...
NPPA Gene Therapy to Encourage Greater Regeneration Following Heart Attack
Researchers at Columbia Engineering have engineered an RNA‑lipid nanoparticle that programs skeletal muscle to secrete a pro‑ANP precursor, which the heart‑specific enzyme Corin converts into active atrial natriuretic peptide. This two‑phase gene‑therapy bypasses the need for direct cardiac drug delivery,...
FDA Pulls GSK's Wellcovorin Autism Approval After Company Request
The U.S. Food and Drug Administration has withdrawn its approval of GlaxoSmithKline's Wellcovorin, a branded leucovorin marketed for autism, after GSK formally requested the action. The reversal, noted in the Federal Register, underscores the unusual nature of pulling a drug...
ArkBio Starts First‑Cohort Dosing of Long‑Acting Antiviral AK0406 in Australian Phase I Trial
Shanghai Ark Biopharmaceutical announced that the first cohort of healthy volunteers has been dosed in a Phase I trial of AK0406, its long‑acting antiviral drug‑Fc conjugate, in Australia. The trial will assess safety, tolerability and pharmacokinetics, and could pave the...
Sumeet SSG Partners Pinnacle Industries to Strengthen Maharashtra’s EMS Fleet
Sumeet SSG BVG Maharashtra EMS has teamed up with Pinnacle Industries to build a new fleet of ambulances for the state’s Emergency Medical Services (MEMS 108) project. The partnership will deliver 1,756 Advanced Life Support, Basic Life Support and neonatal ambulances...
Meta’s Muse Spark AI Asks Users for Health Data, Prompting Privacy and Safety Alarm
Meta launched Muse Spark, an AI assistant that invites users to paste fitness‑tracker, glucose‑monitor or lab‑report numbers for analysis. Early testing revealed inaccurate medical guidance and raised alarms about data privacy, HIPAA compliance and potential misuse of health information.
Telix Pharma Shares Jump Up to 10% After FDA Accepts NDA for Brain Cancer Imaging Agent TLX101‑Px
Telix Pharmaceuticals saw its shares climb as much as 10% in U.S. trading after the FDA accepted its resubmitted New Drug Application for TLX101‑Px, an investigational PET imaging agent for glioma. The agency set a PDUFA goal date of Sept. 11,...
No One Knows Where US Vaccine Policy Goes Next
Health and Human Services Secretary Robert F. Kennedy Jr. has stalled his sweeping vaccine overhaul after a federal judge invalidated the newly appointed ACIP members and blocked changes to the childhood immunization schedule. Kennedy’s earlier moves—dropping Covid‑19 recommendations for healthy...
CDC Testing Pause Puts Clinical Labs at the Center of Public Health Response
The Centers for Disease Control and Prevention has temporarily halted testing for several infectious diseases, including rabies, poxviruses, certain parasites, and lymphocytic choriomeningitis. The pause, framed as a routine quality‑assurance review that began in 2024, is expected to last a...
Cleveland Clinic Catalyzer Program Awards $250K to Quantum Startups
Cleveland Clinic’s Quantum Innovation Catalyzer Program will award up to $250,000, matched with in‑kind resources, to three startups applying quantum computing to health challenges. The selected firms—EntangleBio, Polaris Quantum Biotech, and Singularity Quantum—gain access to IBM’s Quantum System One, the...
Surface‑Engineered Primer Immobilization Enables Simplified and Affordable Nucleic‑Acid Capture for Molecular Diagnostics in Sub‑Saharan Africa
A study introduces a silica‑free nucleic‑acid capture method using polycarbonate surfaces modified with acetone‑UV pretreatment and branched polyethyleneimine linkers. The treatment doubles surface carboxyl groups, and BPEI chemistry attaches about 2.6 times more primers than conventional ethylenediamine links. Fluorescence assays confirm...
Understanding the Role of Oral Surgery in Overall Health
Oral surgery is increasingly recognized as a preventive and restorative tool that safeguards overall health, not just a remedy for complex dental problems. Untreated oral infections can seed bacteria into the bloodstream, triggering systemic inflammation and taxing the immune system....
Patient Scholars Must Coauthor Future Health Research
Publishing with patient scholars should be a requirement in a scientist's career. In this paper, The Evolution of Patient Empowerment and Its Impact on Health Care’s Future, we did exactly that. "𝐴𝑠 𝑤𝑒 𝑙𝑜𝑜𝑘 𝑡𝑜 𝑡ℎ𝑒 𝑓𝑢𝑡𝑢𝑟𝑒, 𝑤𝑒 𝑝𝑜𝑠𝑖𝑡 𝑡ℎ𝑎𝑡 𝑡ℎ𝑒 𝑐𝑜𝑛𝑡𝑖𝑛𝑢𝑒𝑑...
Decoding ORR: What RECIST v1.1 Means for Investors
Investors will often see ORR quoted or displayed for oncology clinical trial results for solid tumors Here's what the CRs/PRs/SDs mean at a high level These are assessed on scans I'm using RECIST v1.1 definitions #learnbiotechinvesting #biotech #investing #BiotechPrometheus https://t.co/eZb86TcoLL
Watch: As AI Makes More Health Coverage Decisions, the Risks to Patients Grow
Health insurers are touting artificial intelligence as a cost‑saving tool for coverage decisions, a claim echoed in recent earnings calls. The Trump administration has launched a pilot using AI to streamline Medicare prior‑authorization, signaling federal support for algorithmic triage. However,...
Reassembling ACIP Is Wasteful Under Anti‑vaccine HHS
Look, reconvening ACIP in any form when you have incurious antivaccine activists/ideologues in charge at HHS = waste of U.S. taxpayer dollars. Until there are changes at HHS, there’s no point. For RFK Jr ACIP is meant to legitimize dangerous...
New Cancer Radiotherapy Machines Arrive at Mpilo Hospital
AT MPILO HOSPITAL, Old Radiotherapy Machines are being decommissioned & the newly procured machines are being installed. These are the “Cancer Machines” Zimbabweans have been talking about. President @edmnangagwa DELIVERED. ED2030🔥🔥🔥🔥 https://t.co/uoDZihr6L6
Assessing Bias and Precision in State Policy Evaluations
The study used state‑level opioid overdose deaths (1999‑2016) to test seven panel‑data estimators under four time‑varying policy scenarios. Simulations revealed that augmented synthetic control reduced bias but raised variance when effects waned, while difference‑in‑differences struggled with non‑monotonic impacts and autoregressive...
For Many Patients Leaving the ICU, the Struggle Has Only Just Begun
The article highlights post‑intensive care syndrome (PICS), a cluster of lasting physical, cognitive, and mental health problems that affect more than half of the roughly 5 million Americans admitted to ICUs each year. It follows the recovery of Joseph Masterson, who...
AllRock Bio Begins Patient Dosing in Phase IIa ROCSTAR Trial
AllRock Bio has begun dosing the first patients in its Phase IIa ROCSTAR trial of ROC‑101, an oral pan‑ROCK inhibitor aimed at pulmonary hypertension. The multi‑center study will enroll up to 30 pulmonary arterial hypertension (PAH) patients and 10 interstitial lung...
Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers
Oncology drug development is shifting toward precision immunotherapies, with biomarkers driving patient selection and trial efficiency. Experts at a Caidya webinar highlighted two trends: novel combination regimens and early integration of biomarker strategies, including companion diagnostics. Early biomarker adoption can...
More Ambulances Are Carrying Blood for Transfusions. Experts Say It Will Save Lives
More U.S. ambulance services are now equipped to carry and administer type O blood in the field, a practice once limited to the military. The National Highway Traffic Safety Administration reports roughly 300 of the 15,000 EMS agencies have pre‑hospital...
Daraxonrasib (RMC-6236): The 2025 Molecule of the Year
Revolution Medicines’ daraxonrasib (RMC‑6236) was crowned 2025 Molecule of the Year after winning 50% of community votes. The oral, tri‑complex molecular glue inhibitor uniquely targets the active GTP‑bound state of KRAS, NRAS and HRAS, covering both mutant and wild‑type isoforms....
Gan & Lee and JW Pharmaceutical Agree on Bofanglutide Commercialisation
Gan & Lee Pharmaceuticals has signed an exclusive licence with JW Pharmaceutical to develop and commercialise the GLP‑1RA bofonaglutide in South Korea. JW will receive a $5 million upfront payment and up to $76.1 million in milestones, bringing total potential value to...
FDA Approves Higher Dose Nusinersen for Spinal Muscular Atrophy
The FDA has approved a higher‑dose regimen of nusinersen (Spinraza) for spinal muscular atrophy, updating both the loading and maintenance phases. The new schedule delivers two larger injections two weeks apart, followed by maintenance doses every four months. Approval follows...
Addressing Pain Points in Organoid Sorting: The Orgadroid
Visienco, a Swiss life‑sciences startup, unveiled the Orgadroid—an automated platform that combines precision robotics with AI‑driven microscopy to sort and classify organoids. The organoid market is forecast to reach $15.01 billion by 2031, growing at a 22.43% CAGR, but manual handling...
Telix Reports US FDA Acceptance of NDA for TLX101-Px (Pixclara) in Glioma Imaging
Telix Pharma announced that the U.S. FDA has accepted the resubmitted New Drug Application for TLX101‑Px, marketed as Pixclara, an investigational 18F‑FET PET imaging agent for glioma detection in adults and children. The agency set a PDUFA action date of...
Amgen’s Lung Cancer Drug Tarlatamab Wins China Approval
Amgen’s bispecific antibody tarlatamab, marketed in the U.S. as Imdelltra, has received approval from China’s National Medical Products Administration. The drug is designed for adults with extensive‑stage small cell lung cancer that has progressed despite chemotherapy. Amgen will commercialize the...
South Korea to Fund Medical AI Device Rollout and More Briefs
South Korea's Ministry of Health and Welfare will allocate 8 billion won ($5.3 million) from the AX‑Sprint programme to fund commercialization of AI‑based medical devices, supporting consortia with hospitals for clinical validation and reimbursement between 2026‑27. Singapore's Nanyang Technological University launched the...
Pulse Biosciences Hires Liane Teplitsky as COO
Pulse Biosciences appointed former Abbott executive Liane Teplitsky as chief operating officer to accelerate its pulsed‑field ablation (PFA) strategy. The company is focusing R&D on the nPulse Cardiac Catheter, a percutaneous device for atrial fibrillation, after promising first‑in‑human data from 150...
UK Cancer Trial Targets Difficult-to-Treat Tumours in Children
A new CAR T‑cell immunotherapy trial, called Mighty, will enroll up to 60 children and young adults with hard‑to‑treat solid tumours in the UK and US. The study targets rhabdomyosarcoma, Ewing sarcoma and soft‑tissue sarcoma, cancers that behave differently from...
Multi-Agent AI Delivers Reliable and Scalable Insights for Single-Cell Omics
Nygen Analytics, a Lund‑based startup founded by computational genomics expert Parashar Dhapola, is deploying multi‑agent AI to streamline single‑cell omics analysis. The platform automates cell‑type annotation, handling millions of cells while reducing error rates that can misguide drug discovery. By...
Kymera Therapeutics Reports Gilead’s Option Exercise to License KT-200, a CDK2 Molecular Glue Degrader
Gilead Sciences exercised its option to exclusively license KT‑200, a first‑in‑class oral CDK2 molecular‑glue degrader, from Kymera Therapeutics. The transaction triggers a $45 million milestone payment, with Kymera eligible for up to $750 million in additional milestones and tiered royalties. Gilead will...
This Week in European MedTech and HealthTech: 10th April 2026
The European Commission released new guidance linking the AI Act to the MDR/IVDR, demanding higher data quality, risk management and human oversight for high‑risk AI medical software. The EU Health Technology Assessment framework is now fully operational, raising the evidence...
Iron‐Based Metal‐Organic Framework MIL‐100(Fe) Regulates Keloid Scarring in a Humanized Keloid Model
The study shows iron‑based metal‑organic framework MIL‑100(Fe) nanoparticles are highly biocompatible, rapidly taken up by keloid fibroblasts, and selectively inhibit the TGF‑β/SMAD pathway, reducing collagen I, collagen III, and P4HA1 expression. In vitro experiments maintained >90% cell viability and curtailed...
The Latino Health Experience: Past and Future
A new PNAS review by Goldman and Pebley examines the Latino health paradox, highlighting the group’s historically higher life expectancy alongside persistent chronic disease, disability, and occupational risks. The authors document how COVID‑19 sharply reduced Latino survival, exposing socioeconomic and...
EBSCO Clinical Decisions Report: 80% of Clinicians Trust Evidence-Based AI Tools
EBSCO Clinical Decisions released a report showing a stark trust gap in AI‑driven clinical decision support. While 89% of clinicians believe AI‑CDS will improve outcomes, 64% of patients would rather see a doctor who does not use AI. Evidence‑based AI...
Radiologists Countersue Former Colleague over Delayed $2M Payout in Sale to Private Equity
Southtowns Radiology Associates and eight physicians filed a countersuit against former partner Gregory R. Ball, alleging he is withholding a $2 million payout tied to the practice’s 2023 sale of its imaging centers to private‑equity firm Rezolut. Ball previously claimed the...
![[Perspectives] Mammography Should Include Artificial Intelligence Support](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/a8b50d033d7e546335a6ec09b92b1dc2.webp)
[Perspectives] Mammography Should Include Artificial Intelligence Support
The Mammography Screening with Artificial Intelligence (MASAI) randomised trial showed that a single radiologist assisted by an AI algorithm achieved higher sensitivity than the traditional double‑reading approach, while preserving specificity. Complementary studies from 2025‑2026 confirm AI’s scalability and equitable performance...
![[Correspondence] Contemporary Non-Invasive Imaging for Coronary Artery Disease](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/e5f5d89f21057c303d0efa1bf29145af.webp)
[Correspondence] Contemporary Non-Invasive Imaging for Coronary Artery Disease
The correspondence highlights three critical clarifications to a recent review on non‑invasive cardiac imaging. First, it stresses that patients with non‑obstructive coronary arteries can still experience angina and ischemia due to microvascular dysfunction or vasospasm. Second, it reinterprets the role...
![[Comment] Liver Disease: Screening for the Elusive Adversary](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/78ddd2d9226c22494f867b221566624c.webp)
[Comment] Liver Disease: Screening for the Elusive Adversary
The Lancet commentary revisits the classic Wilson‑Jungner criteria to evaluate whether population‑wide liver disease screening is justified. It highlights the disease’s long asymptomatic phase and dismal outcomes for late presenters, but points out the lack of consensus on diagnostic thresholds...